Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 24;13(1):10-12.
doi: 10.4103/idoj.idoj_2_22. eCollection 2022 Jan-Feb.

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint

Nusrat Shafiq  1 , Samiksha Bhattacharjee  1 , Samir Malhotra  1
Affiliations
Editorial

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint

Nusrat Shafiq et al. Indian Dermatol Online J. .
No abstract available

PubMed Disclaimer

References

    1. Grover S. Severe cutaneous adverse reactions. Indian J Dermatol Venereol Leprol. 2011;77:3–6. - PubMed
    1. Sasidharanpillai S, Ajithkumar K, Jishna P, Khader A, Anagha KV, Binitha MP, et al. RegiSCAR DRESS (drug reaction with eosinophilia and systemic symptoms) validation scoring system and Japanese consensus group criteria for atypical drug induced hypersensitivity syndrome (DiHS): A comparative analysis. Indian Dermatol Online J. 2022:13. - PMC - PubMed
    1. Kim DH, Koh YI. Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. Allergy Asthma Immunol Res. 2014;3:216–21. - PMC - PubMed
    1. Jeremic I, Ostojic P. Possible DRESS syndrome in a patient with systemic sclerosis and rheumatoid arthritis during treatment with lamotrigine. Arch Med. 2018;10:1–3.
    1. Yang S-C, Chen C-B, Lin M-Y, Zhang Z-Y, Jia X-Y, Huang M, et al. Genetics of severe cutaneous adverse reactions. Front Med (Lausanne) 2021;8:652091. - PMC - PubMed

Publication types